Lv22
170 积分 2025-12-06 加入
Efgartigimod for the treatment of Guillain–Barré syndrome with concurrent posterior reversible encephalopathy syndrome
1个月前
已完结
Efficacy and safety of efgartigimod in patients with neurological autoimmune diseases
1个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
